Last reviewed · How we verify
NCT03836638
The Impact of Age on Botulinum Toxin Potency in Facial Rhytides Treatment
NA trial testing 30 Units of botulinum toxin in Aging in 45 participants. Status unknown.
1 December 2020
Quick facts
| Lead sponsor | St Joseph University, Beirut, Lebanon |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 45 |
| Start date | 1 May 2019 |
| Primary completion | 1 December 2020 |
| Estimated completion | 1 December 2020 |
| Sites | 1 location across Lebanon |
Drugs / interventions tested
- 30 Units of botulinum toxin — full drug profile →
- 50 Units of botulinum toxin — full drug profile →
Conditions studied
- Aging — all drugs for Aging →
- Botulinum Toxin — all drugs for Botulinum Toxin →
- Facial Wrinkles — all drugs for Facial Wrinkles →
Sponsor
St Joseph University, Beirut, Lebanon
Who can join
25 and older, any sex, with Aging or Botulinum Toxin. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Botulinum toxin is approved by the FDA for the treatment of facial wrinkles. Patients are usually older than 45 years and their main demand is to treat pre-existing facial wrinkles. However with the increasing popularity of this technique, younger patients, aged 25 to 35 years, are now seeking botulinum toxin injection as a preventive measure for rhytides. The usual dose used for the treatment of facial rhytides in a female patient older than 45 years is 50 units. No consensus exists concerning the dose of botulinum toxin that should be used in younger patients. Hypothesis: lower dose of botulinum toxin is sufficient to give good and long lasting results in young patients. The objective of this randomized open-label study is to evaluate the effect of lower doses of Botulinum toxin on the facial rythides in young patients.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03836638
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Aging
Currently open trials in the same condition.
- NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
- NCT07099053 — Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging · recruiting
- NCT07504068 — Effects of Physical Exercise and a Nutritional Supplement on Body Composition, Metabolic Function, and Overall Health in · NA · recruiting
- NCT07525453 — Effects of Three Different Exercise Programs on Dynamic Balance in Community-Dwelling Older Adults · NA · recruiting
- NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting
Other St Joseph University, Beirut, Lebanon trials
Trials by the same sponsor.
- NCT05646784 — Gut Microbiota in Mood Disorders in Lebanese Population · NA · completed
- NCT06684093 — Effects of Back Squat Exercise with or Without Blood Flow Restriction in Healthy Adolescent Basketball Athletes · NA · completed
- NCT03834935 — Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis Alba · Phase 2, PHASE3 · unknown
- NCT04822454 — Early Exposure of Medical Students to Night Shifts: Impact on Well-being and Anxiety · NA · completed
- NCT03759964 — Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03836638 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St Joseph University, Beirut, Lebanon
- Last refreshed: 11 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03836638.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing